Members at or near goal weight optimizing body composition Patients who tolerated standard GLP-1 dosing poorly but want the metabolic benefit Members layering the protocol into a coordinated primary care or mental health strategy Patients with significant weight to lose who would be better served by a standard GLP-1 protocol Personal or family history of medullary thyroid carcinoma or MEN 2 Pregnancy, breastfeeding, or planning pregnancy Expected Timeline What to Expect Microdosing is measured in composition, energy, and how you feel not weekly weigh-ins
Pharmacologic Properties and Safety Drug Interactions and Side Effects Regulatory Approvals/Commercial Initially developed by Novo Nordisk, Liraglutide was approved by the US FDA in January 2010 with the commercial name Victoza
At Yoo Direct Health, peptide protocols are individualized based on patient goals, health status, and response monitoring
At 4-6g of Fibersol with each meal, clinical studies have shown that Fibersol: In addition to the beneficial effects on GLP-1, satiety and blood sugar, Fibersol provides other positive wellness impacts: The satiety, GLP-1 and nutritional benefits of Fibersol can easily be added to GLP-1 companion products
Discuss specifics with your provider
Because the model was applied to evaluate the risk of first MACE in participants with different eGFR and UACR values, the subgroups eGFR 60 mL/min/1.73 m 2 (normal or mildly reduced kidney function) and UACR 300 mg/g subgroups, respectively, had an eGFR 300 mg/g were 1.53 [1.14;2.04] and 2.52 [1.84;3.42] compared with the UACR 300 mg/g: 2.37 [1.70;3.27]